PRTODAY / NewswireToday Free press release distribution service network

More news: Nanotechnology
Agency / Source: Nanopartz

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!

New Manufacturing Method Results in Non-Cytotoxic Nanorods for In-Vivo Therapeutics and Imaging - Gold Nanorods are now available for in-vivo, non-invasive photothermal cancer therapy
New Manufacturing Method Results in Non-Cytotoxic Nanorods for In-Vivo Therapeutics and Imaging

 

NewswireToday - /newswire/ - Kailua, HI, United States, 10/16/2008 - Gold Nanorods are now available for in-vivo, non-invasive photothermal cancer therapy.

   
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Nanotechnology Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

A revolutionary new gold nanorod manufacturing method has been developed at Nanopartz where their patent pending gold nanorods are proving their ability to be the future in-vivo nanoparticle for the detection and treatment of solid tumor cancers – without the need for surgery.
This new proprietary method, removes the cytotoxic cetyl trimethylammonium bromide (CTAB) capping agent necessary for manufacturing, replacing it with polyethylene glycol (PEG). PEG has a low toxicity and is used in a variety of products. It is the basis of a number of laxatives and skin creams and many other well known products. The combination of the gold nanorods with PEG coatings, name Ntracker, has shown shown half-life circulation times of greater than 17 hours in mice.

For years researchers have known of the advantages offered by gold nanorods for in-vivo and in-vitro applications. Gold nanorods have unprecedented photothermal absorption characteristics. That is, they efficiently convert light to heat. In addition, gold nanorods are very good light scatterers. These two properties, light scattering and photothermal absorption, are the two properties necessary for successful in-vivo therapeutics, imaging, and diagnostics.

But until now, the limitation on commercializing gold nanorods for in-vivo and in-vitro applications has been toxicity. Nanopartz has now solved this problem with the release of their Ntracker nanorods.
In solid tumor cancer therapy, the gold nanorods can be functionalized with coatings that are specific or even non-directional for solid tumor cancers. Once injected, the nanorods circulate throughout the body, and over time, concentrate in the targeted solid tumor cancer. The nanorods, manufactured to absorb at specific near-infrared wavelengths, readily convert near-infrared light to heat. Since human skin and tissue is fairly transmissive to near-infrared light, a low power near-infrared laser may be used outside the body to heat the solid tumor to temperatures that destroy the tumor cells, not affecting healthy tissue adjacent to the tumor - all without the need for surgery.

As a contrast enhancement agent, gold nanorods may be manufactured to scatter at discrete wavelengths anywhere in the near-infrared. This property lends itself to the ability to enhance detection of solid tumor cancer that might normally be missed using conventional techniques. Currently, researchers are using nanorods as a contrast enhancement for Photoacoustic Imaging, Optical Coherence Tomography, as well as Surface Enhanced Raman Scattering.

Other potential applications of gold nanorods include the use to improve the efficiency of solar cells, for use in negative refractive index materials (i.e. Harry Potter Invisibility Cloak), as well as for optical polarizers for sunglasses.
"We are very excited at the potential applications of these nanorods,” said Christian Schoen, President of Nanopartz.

 
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Nanotechnology Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

Agency / Source: Nanopartz

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Nanotechnology articles,
CATCH Visitors via Your Competitors Announcements!


New Manufacturing Method Results in Non-Cytotoxic Nanorods for In-Vivo Therapeutics and Imaging

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Christian Schoen 
866-721-7796 sales[.]nanopartz.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Nanopartz securities in any jurisdiction including any other companies listed or named in this release.

Nanotechnology via RSS
AddThis press release: New Manufacturing Method Results in Non-Cytotoxic Nanorods for In-Vivo Therapeutics and ImagingAdd Nanotechnology News to My MSNAdd Nanotechnology News to My Yahoo!Add NewswireToday Nanotechnology Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner Twitter /NewswireToday

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!


Read Latest Articles From Nanopartz / Company Profile



MIT Researcher Develops New Method For Curing Cancer Using Gold Nanorods
Nanopartz First to Release Gold Nanowires
New Manufacturing Method Results in Non-Cytotoxic Nanorods for In-Vivo Therapeutics and Imaging
Nanopartz Releases a New Line of Highly Monodisperse Gold Nanorods

Reserve This Permanent SPACE

Your LOGO permanently HERE on Newswire Today most visited Page start at $295 per month

 
Sponsored Links


Visit  Pickerel Lake Recovery Treatment Center

Visit  Gripsell










 
  ©2012 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri- bution today investor relation successful internet entrepreneur free newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)